No orthodox practices disrupt the vaginal flora and expose it to pathogenic microorganisms including group B Streptococcus β hemolytic (GBS). The study aims to describe the bacterial profil and resistance of GBS to antibiotics. Retrospective study included 640 women at Cotonou suspected of vaginal infections or vaginal discharge during 1 st January 2004 to 31 st December 2015. Three swabs were collected and analyzed to identify the bacteria by standard biochemical reactions, diagnosis of bacterial vaginosis and identification of Trichomonas vaginalis, yeasts and leukocyte count. Antibiogram was performed according to the CA-SFM. Among 640 samples, 502 (78.4%) were positive. The most encountered microorganisms were Candida albicans (37.45%) and GBS (19.92%). GBS sensitivity ranged from 80-100% for augmentin, pefloxacin and nitrofuran. But resistance was observed to netilmicin, tetracyclin, cefoxitin, cephalotin, thiamphenicol, trimethoprim / sulfamethnoxazole between 80-100%. A high percentage of resistance is the result of uncontrolled access to antibiotics and improper antibiotic policy. Routine susceptibility testing will allow to take appropriate treatment of GBS in Benin.

Antimicrobial resistance became a growing public health problem in the world and Escherichia coli (E. coli) appeared as one of nine bacteria commonly causing infections in community and hospitals. It prevalence and it resistance to antibiotics were evaluated in Benin throughout an eleven year period. In this retrospective study, routine urine samples from patients collected at the National Laboratory (NL) of Health Ministry during the period 2005-2015 were analyzed. Samples higher than 103 CFU/mL bacterial growth were considered positive and for these cases, the bacteria were identified and Antimicrobial Susceptibility Test (AST) was performed. From the 4467 samples analyzed, 1455 (32.6%) were positive with E. coli preponderance (38.3%) of all isolated germs and (58.5%) of enterobacteriaceae. Most of the isolates were susceptibility to netilmicin (80%), gentamycin (93%), chloramphenicol (70%), pipemidic acid (60%), nalidixic acid (75%), ciprofloxacin (75%), amoxicillin/clavulanic acid (80%) and nitrofurantoin (100%). Susceptibility rates increased for cefotaxim (78-100%), ceftriaxon (71-100%) and aztreonam (67-100%). Resistances were observed for minocyclin (70%), Trimethoprim/Sulfamethoxazole (TMP-SMX) (60%), ampicillin (67%), amoxicillin (75%), carbenicillin (86%), cephalothin and cephalexin (50 and 80% respectively). The use of drugs such as minocyclin, ampicillin, amoxicillin, carbenicillin, cephalothin, cephalexin and trimethoprim/sulfamethoxazole does not seem appropriate for empirical treatment of UTI in Benin.